CoChat

The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion

Open access
Currow, David C., Maddocks, Matthew, Cella, David, Muscaritoli, Maurizio · 2018 · International Journal of Molecular Sciences

Abstract

Cancer cachexia is a multilayered syndrome consisting of the interaction between tumor cells and the host, at times modulated by the pharmacologic treatments used for tumor control. Key cellular and soluble mediators, activated because of this interaction, induce metabolic and nutritional alterations. This results in mass and functional changes systemically, and can lead to increased morbidity and reduced length and quality of life. For most solid malignancies, a cure remains an unrealistic goal, and targeting the key mediators is ineffective because of their heterogeneity/redundancy. The most beneficial approach is to target underlying systemic mechanisms, an approach where the novel non-peptide ghrelin analogue anamorelin has the advantage of stimulating appetite and possibly food intake, as well as promoting anabolism and significant muscle mass gain. In the ROMANA studies, compared with placebo, anamorelin significantly increased lean body mass in non-small cell lung cancer (NSCLC) patients. Body composition analysis suggested that anamorelin is an active anabolic agent in patients with NSCLC, without the side effects of other anabolic drugs. Anamorelin also induced a significant and meaningful improvement of anorexia/cachexia symptoms. The ROMANA trials have provided unprecedented knowledge, highlighting the therapeutic effects of anamorelin as an initial, but significant, step toward directly managing cancer cachexia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19113471

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Clinical relevance of low LBM. ADL, activities of daily living; LBM, lean body mass.
Figure 1 Clinical relevance of low LBM. ADL, activities of daily living; LBM, lean body mass.CC BY · PubMed Central
Figure 2 Schematic of the complex, multilayered, and multi-organ nature of cancer cachexia and the layers targeted by anamorelin in this process.
Figure 2 Schematic of the complex, multilayered, and multi-organ nature of cancer cachexia and the layers targeted by anamorelin in this process.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 4

  1. Currow, 2016, Pooled efficacy data from ROMANA 1 and ROMANA 2, two phase 3 trials of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with cachexia, Support. Care Cancer, 24, S23
  2. Crawford, J.C., Johnston, M.A., Hancock, M.L., Small, S.G., Taylor, R.P., Dalton, J.P., and Steiner, M.S. (2014, January 26–28). Enobosarm, a selective androgen receptor modulator (SARM), increases lean body mass (LBM) in advanced NSCLC patients; updated results of two pivotal, international Phase 3 trials. Proceedings of the MASCC/ISOO International Symposium on Supportive Care in Cancer, Miami, FL, USA. MASCC-0546.
  3. Cella, 1993, Quality of life and nutritional well-being: Measurement and relationship, Oncology, 7, S105
  4. Gelhorn, H.L., Gries, K.S., Duus, E.M., Bourne, R.K., Friend, J.E., Speck, R.M., Leidy, N.K., and Cella, D. (2016, January 19–22). Psychometric properties of the FAACT Additional Concerns Subscale (A/CS) for measurement of anorexia in patients with non-small cell lung cancer. Proceedings of the International Society for Quality of Life Research 23rd Annual Conference, Copenhagen, Denmark. Poster 1005.

Cited by

See all 28

Metadata

Authors
Currow, D. C., Maddocks, M., Cella, D., & Muscaritoli, M.
Affiliations
  • University of Technology Sydney (AU)
  • King's College London (GB)
  • Northwestern University (US)
  • Sapienza University of Rome (IT)
Corresponding author
Muscaritoli, Maurizio
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-11-05
Volume
19
Issue
11
Pages
3471
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2900369002
Cited by
27
References
92
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 8 · 2019: 3
FWCI
0.53
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion)
Funders
Helsinn Healthcare SA (NA)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
anamorelin, cancer cachexia, non-small cell lung cancer, appetite stimulation, lean body mass, anabolic therapy, muscle mass gain, anorexia, body composition
MeSH terms
Body Weight, Cachexia, Carcinoma, Non-Small-Cell Lung, Humans, Hydrazines, Oligopeptides, Hand Strength, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion. https://app.cochat.ai/papers/10.3390/ijms19113471
The paper
Currow, D. C., Maddocks, M., Cella, D., & Muscaritoli, M. (2018). Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19113471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.